# Biogen MA Inc. – FDA Inspection, Mar 23, 2017

Source: https://www.keypedia.com/records/fda_inspections/biogen-ma-inc/7be2ce18-c488-465d-ad5e-44bd30dc6af8
Source feed: FDA_Inspections

> FDA inspection 1016280 of Biogen MA Inc., March 23, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1016280
- Company Name: Biogen MA Inc.
- Inspection Date: 2017-03-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1252412 - 2024-07-12
- [FDA Inspection 1084879 - 2019-02-15](https://www.keypedia.com/records/fda_inspections/biogen-ma-inc/08fa2f62-a29f-4b41-b6f7-c2e98797b6b0)
- FDA Inspection 1066958 - 2018-06-13
- [FDA Inspection 999559 - 2016-12-23](https://www.keypedia.com/records/fda_inspections/biogen-ma-inc/63d1cd7c-ce1d-438e-9845-7e84a02d3ed8)
- FDA Inspection 978930 - 2016-01-15

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/burnell-m-henry/dece4407-3597-4a58-8756-5abf9db43bbc)

Company: https://www.keypedia.com/companies/biogen-ma-inc/85b778d2-1e69-485d-9e93-05c656646fa2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
